Background The management of mild asthma has lacked an over-the-counter (OTC) option
aside from inhaled epinephrine, which is available in the United States. However, inhaled …

Background Recent asthma guidelines, such as the Global Initiative for Asthma (GINA),
recommend in adult patients as-needed inhaled corticosteroids (ICS)-formoterol as an …

Abstract Background The Global Initiative for Asthma recommends the use of as-needed low-
dose inhaled corticosteroid (ICS)-formoterol as a preferred controller therapy for patients …

Background: The results of a recent meta-analysis comparing 2 inhaled corticosteroids,
fluticasone propionate (FP) and budesonide, demonstrated that FP had an improved efficacy …

Background Comparative effectiveness of the budesonide–formoterol fumarate dihydrate
combination (BFC) and the fluticasone propionate–salmeterol combination (FSC) therapy on …

Background As-needed budesonide/formoterol is effective in patients with mild asthma for
whom low-dose inhaled corticosteroid (ICS) maintenance therapy is appropriate. We …

Introduction Budesonide-formoterol taken as needed is an emerging treatment for mild
asthma. Objective We used data from the SYGMA studies to assess the safety of As-needed …

OBJECTIVE: To evaluate direct asthma-related costs in Swedish primary care in a real-life
setting. Design: 12-month open-label study. SETTING: Swedish primary care in a real-life …

OBJECTIVES: To compare the cost‐effectiveness of budesonide‐formoterol in a single
inhaler used as both maintenance and reliever medication versus clinician‐directed titration …

Background In patients with mild asthma, as-needed use of an inhaled glucocorticoid plus a
fast-acting β2-agonist may be an alternative to conventional treatment strategies. Methods …